Chondroprotective Effects of Mulberroside a on Osteoarthritis Via Restoring Impaired Autophagy and Suppressing the MAPK/NF-κB/PI3K-AKT-mTOR Signaling Pathways

Rui Lu,Zhenni Wei,Zhenggang Wang,Shimeng Xu,Kai Sun,Peng Cheng,Xiaojian Huang,Hongbo You,Fengjing Guo,Shuang Liang,An-min Chen
DOI: https://doi.org/10.2139/ssrn.4246389
2022-01-01
SSRN Electronic Journal
Abstract:Osteoarthritis (OA) is an age-related degenerative disease characterized by loss and destruction of cartilage and by chronic inflammation as the pathogenic mechanism. Mulberroside A (MA), a natural bioactive withanolide, demonstrates anti-inflammatory properties in various diseases; however, little is known about the effect of MA on OA. Our purpose was to examine the role of MA on OA and to identify the mechanism through which it exhibits chondroprotective effects. In in vitro experiments, interleukin-1beta (IL-1β) was applied to induce the OA chondrocytes. The data revealed that MA improved the inflammatory response, anabolism, and catabolism in IL-1β–induced chondrocytes. In addition, the anabolism–promoting, catabolism and inflammation–inhibiting effects of MA were attributed to the suppressing of the MAPK (mitogen-activated protein kinase), NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), and PI3K-AKT-mTOR signaling pathways, as well as promoting the autophagy process. Destabilized medial meniscus (DMM)–established OA mice models were applied in in vivo study. The data revealed that intra-articular injection of MA reduced the cartilage destruction, as well as reversed the change of anabolic and catabolic-related proteins in DMM-induced OA models. Thus, the study indicates that MA exhibits a chondroprotective effect and might be a promising agent for OA treatment.Funding Information: This study was supported by the National Natural Science Foundation of China (No. 506 81672168, China). Declaration of Interests: The authors declare that they have no competing interests. Ethics Approval Statement: The study was approved by the Ethics Committee on Animal Experimentation of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.
What problem does this paper attempt to address?